Impact of a Validated Composite Comorbidity Score on Outcomes in Patients Treated with CAR T-Cell Therapy for Diffuse Large B Cell Lymphoma (DLBCL): A Multicenter Real-World Evidence (RWE) Study
Year: 2022
Type: article
Study design: Observational Study
Source: Blood
Authors: Geoffrey Shouse, Andy Kaempf, Max J. Gordon, David Yashar, Audrey M. Sigmund, Gordon Smilnak, Steven M. Bair, Agrima Mian, Lindsey A. Fitzgerald, Amneet Bajwa, Samantha Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M. Stephens, Manali Kamdar, Brian T. Hill, Jordan Gauthier, Reem Karmali, Loretta J. Nastoupil, Adam S Kittai, Alexey V Danilov
Institutions: City Of Hope National Medical Center, Oregon Health & Science University, OHSU Knight Cancer Institute, The Ohio State University, Northwestern University, Hospital of the University of Pennsylvania, Cleveland Clinic, University of Utah, Huntsman Cancer Institute, The Ohio State University Wexner Medical Center, University of Washington, Fred Hutch Cancer Center, Swedish Medical Center, University of Colorado Cancer Center, The University of Texas MD Anderson Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310108513